Clinical sessions

The following sessions have been identified as particularly pertinent to clinician scientists attending the BNA2019 Festival of Neuroscience. 


13:00 - 14:40
S3: Advances in Child Neurology 2019 
Convened by the British Paediatric Neurology Association
Anne Marie Childs, Leeds General Infirmary, UK
Katharina Vezyroglou, UCL-Great Ormond Street Institute of Child Health, UK
Ming Lim, Evelina Childrens Hospital, London, UK
Helen Cross, UCL-Great Ormond Street Institute of Child Health, UK

16.20 - 18.00
S8: Mental illness in children and adolescents: neuroscience, ethics and practice in psychopharmacology
Convened by the British Association of Psychopharmacology and the International Neuroethics Society

Mitul Mehta or Paramala Santosh, King's College, London, UK.
Judith Homberg, Radboud University, The Netherlands.
Argyris Stringaris, National Institute of Mental Health, Bethesda, US.
Gabriela Pavarini, University of Oxford, UK.
Chair: Mitul Mehta, KCL, UK.



08.30 - 09.30
Plenary: ​Why do some people become psychopaths?
Professor Essi Viding, University College London, UK

09.30 - 11.10
S13: Characterizing addiction using neuroimagingJeff Dalley, University of Cambridge, UK (co-chair)
Wolfgang Sommer, Mannheim CIMH, Germany - Developing better treatments for relapse prevention using a systems biology approach
Louise Paterson, Imperial College London, UK - Potential of NK1 antagonism to treat addiction in man 
Rebecca Elliott, University of Manchester, UK (co-chair) - Role of DRD3 and modulation of reward in treating addiction in man ​

11.50 - 12.50
Plenary: ​The neuroscience of addiction
Professor Barry Everitt, University of Cambridge

15.30 - 17.10
S17: Cannabinoids: therapeutic potential in CNS disorders
Convened by Neuroscience Ireland

Eric Downer, Trinity College Dublin, Ireland (co-chair) - Therapeutically targeting innate immune signalling mechanisms in CNS disorders with cannabinoids​
Roger Pertwee, University of Aberdeen, UK - Pharmacological actions and potential novel therapeutic uses of certain plant and synthetic cannabinoids
Eva Marco, Complutense University of Madrid, Spain - Cannabinoids in emotional control, is there a sex-dependent effect? 
Michelle Roche, NUI Galway, Ireland (co-chair) - Endocannabinoid modulation of neuroinflammation: implications of psychiatric disorders and pain​

S18: Developing disease modifying therapies for Parkinson’s
Convened by Parkinson’s UK

Maria G. Spillantini, University of Cambridge, UK - Alpha-synuclein's conversion from an essential protein to a neuronal killer?
Anthony HV Schapira, University College London, UK (co-chair) - Glucocerebrosidase: A risk factor for Parkinson's leads to the discovery of novel therapeutic approaches
Giovanna R Mallucci, University of Cambridge, UK (co-chair) - PERK pathway modulation offers a new lease of life for old drugs as Parkinson's therapies
Richard Mead, University of Sheffield, UK - Virtual Biotech partnership: Novel funding to harness the neuroprotective potential of Nrf2-ARE pathway activation

Plenary: Stem Cell Therapy for Parkinson´s Disease: Current status and future perspectives.
Professor Anders Björklund



09.30 - 11.10
S22: New directions in epilepsy research
Convened by Epilepsy Research UK

Gabriele Lignani, University College London, UK (co-chair) - Modulating promoter activity to treat intractable genetic and acquired epilepsy​
Sukhvir Wright, Aston University, UK (co-chair) - Autoimmune epilepsy: from symptoms to synapse​
Alfredo Gonzalez-Sulser, University of Edinburgh, UK - GABAergic Medial Septal Neurones and their role in models of Temporal Lobe Epilepsy
Andrei Ilie, University of Oxford, UK - Phasic and tonic GABAergic signalling combine with membrane potential dynamics to regulate intracellular chloride during seizures

09.30 - 11.10
S23: Neuromuscular disorders – cutting edge of translation
Convened by the Association of British Neurologists

Mary Reilly, Association of British Neurologists, UK (co-chair) - Inherited neuropathies: The first treatable neurodegenerative diseases ​
Orla Hardiman, Trinity College Dublin, Ireland - MND – A model neurodegeneration 
Michael Hanna, National Hospital for Neurology & Neurosurgery, London, UK (co-chair) - Channelopathies 2019: exciting new phenotypes, mechanisms and therapies:  Where exciting implies excitability ​
Hugh Willison, Southern General Hospital, Glasgow, UK - The sweet side of inflammatory neuropathy 

11.50 - 12.50
Plenary: ​The new three Rs and what they mean for neuroscientists: reproducibility, replicability and reliability of research
Professor Uta Frith, University College London

15.30 - 17.10
S28: Let’s stick together - neurodegeneration an expanding disease spectrum
Convened by the Association of British Neurologists

Timothy Lynch, University College Dublin, Ireland - Subtypes of Parkinson's disease and parkinsonism in Ireland (co-chair) - Subtypes of Parkinson's disease and parkinsonism in Ireland​
Jonathan Schott, National Hospital for Neurology and Neurosurgery, London, UK (co-chair) - Determining the prevalence and causes of preclinical Alzheimer’s disease and cerebrovascular disease – results from a British Birth Cohort
Matthew Jones, University of Manchester, UK - Unravelling FTD – syndromes, proteins, genes and treatments 
Paola Piccini, Imperial College London, UK - Advances in Neuroimaging in PD

18:30 - 19:30
Public lecture: Inflamed Depression 
Professor Ed Bullmore, University of Cambridge



09.30 - 11.10
S34: Vascular Neurology 
Convened by the Irish Institute of Clinical Neuroscience
Keith Muir, University of Glasgow, UK - Neuroimaging techniques  to optimise selection of acute ischaemic stroke patients for IV thrombolysis or mechanical thrombectomy
Dominick McCabe, Trinity College Dublin, Ireland (co-chair) - Update on translational platelet science / haemostasis in ischaemic cerebrovascular disease​
Aine Merwick, Beaumont Hospital, Ireland - Optimising risk-stratification to guide management following a transient ischaemic attack
Alex Leff, UCL, UK (co-chair) - Novel approaches to rehabilitation following stroke​

Plenary: Appetite and the brain
Professor Lora Heisler, University of Aberdeen
Convened by the British Society for Neuroendocrinology